Trademark Overview
On Thursday, December 18, 2025, a trademark application was filed for 4TISSUE with the United States Patent and Trademark Office. The USPTO has given the 4TISSUE trademark a serial number of 79448423. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, April 28, 2026. This trademark is owned by 4Tissue BV. The 4TISSUE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Research, design and development in the field of biomaterials, regenerative medicine and drug delivery systems; medical research in the field of regenerative medicine and drug delivery systems; scientific studies in the field of biomaterials, regenerative medicine and drug delivery systems; testing and inspection services in the field of biomaterials, regenerative medicine and drug delivery systems; scientific laboratory services; scientific and medical research and development relating to products, technologies and treatments in the field of regenerative medicine and drug delivery systems for market approval through, among other things, clinical validation, regulatory approval and conducting clinical trials related thereto; culturing cells and tissues for scientific research purposes; synthesis (production) of biomaterials for scientific research purposes.
Medical services in the field of regenerative medicine and drug delivery systems; medical treatments, including injections, implants, oral, topical and external administrations, in the field of regenerative medicine and drug delivery systems; medical laboratory services; medical advice in the field of regenerative medicine and drug delivery systems; providing medical information in the field of regenerative medicine and drug delivery systems.
Medical preparations aimed at restoring the function of cells, tissues and organs; medical products, in particular hydrogels, gels, scaffolds [biological implants], matrices [biological tissue cultures] and tissue mimics, aimed at functional restoration of cells, tissues and organs; medical preparations and products that serve as carriers for drugs, cells and cell derivatives.
